Consistent with the above result, significant decreases of IL-15Rα levels in schizophrenia patients were also found compared with healthy controls (p = 0.031) or depressive patients (p = 0.016) when controlling for age, sex and doses equivalent to olanzapine. The gene discussed is IL15RA; the disease is schizophrenia.